F17464

DRUG2 trials

Sponsors

Pierre Fabre Medicament

Conditions

Healthy VolunteersSchizophrenia

Phase 1

Brain Imaging Study of F17464

CompletedNCT01689038

Pierre Fabre MedicamentHealthy Volunteers

Start: 2012-11-30End: 2013-02-28Updated: 2013-02-15

Phase 2

F17464 in Acute Schizophrenia Trial

CompletedNCT02151656

Pierre Fabre MedicamentSchizophrenia

Start: 2014-06-30End: 2015-12-31Updated: 2016-12-16